This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should SPDR Portfolio S&P 500 Value ETF (SPYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYV
6 Keys to a Healthy ETF Portfolio
by Sweta Killa
Similar to the six vital nutrients required for good health, we have highlighted six keys for building a healthy ETF portfolio.
S&P 500 Tops 4,000: Are ETFs Awaiting More Gains?
by Sanghamitra Saha
The S&P 500 topped 4,000-mark lately. Market buzz and industry fundamentals indicate that there is room for more growth.
Don't Let Underperformance in Growth ETFs Fool You
by Sanghamitra Saha
Focus on the technology sector, rising virus cases, talks of a hike in capital gains tax and still-low rates should bring the growth investing back in favor.
Tax Hike Not a Big Concern? Play S&P 500 ETFs
by Sanghamitra Saha
Talks are doing rounds that Centrist Democrats in Congress are apparently opposing Biden's corporate and capital gains tax proposal. We may see a lesser hike in tax rates if at all there is a tax hike in the near term.
Top-Ranked Value ETFs to Add to Your Portfolio
by Sweta Jaiswal, FRM
Accelerated coronavirus vaccine rollout, a fresh round of fiscal stimulus and the economic reopening may lead to faster U.S. economic recovery and present a strong case for outperformance by value ETFs in 2021.
Fed Bumps Up Economic Growth Forecasts: ETFs to Play
by Sanghamitra Saha
As widely expected, the Fed held interest rates steady at a near-zero level in its latest meeting.
4 Sectors & Their ETFs Offering Great Value Now
by Sanghamitra Saha
Wall Street has rallied nicely this year on vaccine and fiscal stimulus optimism. But gains have mainly been supported by value stocks.
Are You a Fan of Ark ETFs' Cathie Wood? Follow This Portfolio
by Sanghamitra Saha
Ark Investment Management founder Cathie Wood deserves cryptocurrency demands 20% weight in your portfolio while bonds and equities should take other 20% and 60%, respectively.
Top ETF Stories of February Worth Watching in March
by Sanghamitra Saha
Though the start of the month was upbeat, rising rate worries triggered a crash at month-end. Can markets rally higher in March on EUA of J&J's vaccine and chances of passage of Biden's stimulus bill?
Great Rotation From Bonds to Stocks: ETFs to Win
by Sanghamitra Saha
Rising rate worries have triggered a bond selloff lately and brightened the appeal for value stocks.
Citi Foresees a 10% Stock Pullback Likely: ETFs to Save You
by Sanghamitra Saha
Citi strategists said in a report lately that a 10% pullback "seems very plausible."
5 ETFs to Benefit From Treasury Yield Surge
by Sanghamitra Saha
Rates have been rising fast in the United States over the past few weeks on growing risk appetite and reflationary optimism.
ETFs to Play S&P 500's Best Inauguration Day Since 1985
by Sanghamitra Saha
The S&P 500 recorded one of the best Inauguration Day returns this year. Buy the rally with these ETFs.
Investing Strategies to Follow on Democratic Senate and House
by Sanghamitra Saha
Democratic taking control of both House and Senate, these investing strategies should prosper in the coming days.
Top ETF Stories of Fourth-Quarter 2020
by Sanghamitra Saha
The year 2020 as a whole could easily be attributed to the COVID-19 outbreak.
Will "Santa Rally" 2020 Be Unusual? 5 ETFs to Stay Steady
by Sanghamitra Saha
Santa Claus rally refers to the jump in stock prices in the week between Christmas and New Year's Day. But this year things could change.
5 ETFs to Grab for a Really Good Deal on Black Friday
by Sanghamitra Saha
Wall Street has been super upbeat in recent sessions on vaccine hopes. Value has been pretty cheap versus momentum and growth.
Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism
by Sweta Killa
The potential arrival of a coronavirus vaccine will end the pandemic crisis, keeping the economy recovery intact, and will boost consumer spending and in turn lift value stocks.
Value or Growth: Which ETFs to Play Ahead?
by Sanghamitra Saha
If things turn right on the vaccine front in the coming days, one can surely expect a rise in economic activity and bond yields, and a rally in value stocks.
Time for Value ETFs Ahead?
by Sanghamitra Saha
Value stocks and ETFs have lagged the growth ones this year due to an extremely low level of interest rates. But the momentum could shift ahead.
Healthcare and Value: 2 ETFs to Watch for Outsized Volume
by Sweta Killa
IHF and SPYV saw massive trading volumes on Friday.
Trump or Biden, These Value ETFs & Stocks Are Set to Soar
by Sweta Killa
The historical patterns show that elections have a long track of doing wonders for value stocks.
ETFs to Win on S&P's Upside Potential on Way to Record Close
by Sanghamitra Saha
ETFs to gain as the S&P 500 topped the record closing briefly and it has solid upside potential too.
5 ETFs At the Forefront of the Great Rotation
by Sweta Killa
Given the great rotation, some ETFs, which were depressed this year, have showed strong performance last week.